Scientists launch major study to unravel mysteries of muscle inflammation
NCT ID NCT05738824
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to collect medical information and tissue samples from 500 people with suspected or confirmed inflammatory muscle diseases, as well as healthy volunteers. Researchers will use blood, muscle, and skin samples to study what causes these diseases and how they progress. The goal is to improve diagnosis and future treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could help doctors better diagnose and treat inflammatory muscle diseases in the future.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly test any new drug or therapy, so benefits may take years to emerge.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATION IN SKELETAL MUSCLE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Engineered immune cells take aim at Hard-to-Treat muscle disease
- Engineered immune cells take aim at Hard-to-Treat autoimmune diseases
- Video game rehab boosts muscle power in rare muscle disease
- New cell therapy hopes to tame tough autoimmune diseases
- Engineered immune cells aim to tame stubborn autoimmune diseases
- Experimental cell therapy takes on lupus and other autoimmune diseases